[1] Ginalska-Malinowska M.Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency-the next disease included in the neonatal screening program in Poland[J].Dev Period Med,2018,22(2):197-200. [2] Bourdeau I,Salle SPL,Lacroix A.Adrenocortical hyperplasia:A multifaceted disease[J].Best Pract Res Clin Endocrinol Metab,2020,34(3):101386. [3] Daae E,Feragen KB,Nermoen I,et al.Psychological adjustment,quality of life,and self-perceptions of reproductive health in males with congenital adrenal hyperplasia:a systematic review[J].Endocrine,2018,62(1):3-13. [4] Gidlöf S,Falhammar H,Thilén A,et al.One hundred years of congenital adrenal hyperplasia in Sweden:a retrospective,population-based cohort study[J].Lancet Diabetes Endocrinol,2013,1(1):35-42. [5] Speiser PW,Arlt W,Auchus RJ,et al.Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency:an endocrine society clinical practice guideline[J].J Clin Endocrinol Metab,2018,103(11):4043-4088. [6] Nordenstrom A,Falhammar H.Management of endocrine disease:diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency[J].Eur J Endocrinol,2019,180(3):127-145. [7] 中华医学会儿科学分会内分泌遗传代谢病学组.先天性肾上腺皮质增生症21-羟化酶缺陷诊治共识[J].中华儿科杂志,2016,54(8):569-576. [8] Musa N,Asem N,Basyony S,et al.Assessment of health-related quality of life in Egyptian children and adolescents with congenital adrenal hyperplasia[J].J Pediatr Endocrinol Metab,2020,33(2):295-304. [9] Gilban DLS,Alves Junior PA,Beserra ICR,et al.Health related quality of life of children and adolescents with congenital adrenal hyperplasia in Brazil[J].Health Qual Life Outcomes,2014,12:107. [10] Vijayan R,Bhavani N,Pavithran PV,et al.Metabolic profile,cardiovascular risk factors and health-related quality of life in children,adolescents and young adults with congenital adrenal hyperplasia[J].J Pediatr Endocrinol Metab,2019,32(8):871-877. [11] Falhammar H,Frisen L,Hirschberg AL,et al.Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency:a Swedish population-based national cohort study[J].J Clin Endocrinol Metab,2015,100(9):3520-3528. [12] Bouvattier C,Esterle L,Renoult-Pierre P,et al.Clinical outcome,hormonal status,gonadotrope axis,and testicular function in 219 adult men born with classic 21-hydroxylase deficiency.A French national survey[J].J Clin Endocrinol Metab,2015,100(6):2303-2313. [13] Jenkins-Jones S,Parviainen L,Porter J,et al.Poor compliance and increased mortality,depression and healthcare costs in patients with congenital adrenal hyperplasia[J].Eur J Endocrinol,2018,178(4):309-320. [14] Engels M,Gehrmann K,Falhammar H,et al.Gonadal function in adult male patients with congenital adrenal hyperplasia[J].Eur J Endocrinol,2018,178(3):285-294. [15] Falhammar H,Frisén L,Norrby C,et al.Reduced frequency of biological and increased frequency of adopted children in males with 21-hydroxylase deficiency:a Swedish population-based national cohort study[J].J Clin Endocrinol Metab,2017,102(11):4191-4199. [16] El-Maouche D,Arlt W,Merke DP.Congenital adrenal hyperplasia[J].Lancet,2017,390(10108):2194-2210. [17] Turcu AF,Auchus RJ.Novel treatment strategies in congenital adrenal hyperplasia[J].Curr Opin Endocrinol Diabetes Obes,2016,23(3):225-232. [18] Zainuddin AA,Grover SR,Ghani NAA,et al.Health-related quality of life of female patients with congenital adrenal hyperplasia in Malaysia[J].Health Qual Life Outcomes,2020,18(1):258. [19] Improda N,Barbieri F,Ciccarelli GP,et al.Cardiovascular health in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxilase deficiency[J].Front Endocrinol(Lausanne),2019,10:212. [20] Yau M,Vogiatzi M,Lewkowitz-Shpuntoff A,et al.Health-related quality of life in children with congenital adrenal hyperplasia[J].Horm Res Paediatr,2015,84(3):165-171. [21] Engberg H,Butwicka A,Nordenström A,et al.Congenital adrenal hyperplasia and risk for psychiatric disorders in girls and women born between 1915 and 2010:a total population study[J].Psychoneuroendocrinology,2015,60:195-205. |